InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies. These products are used for procedures such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation, as well as for women's health conditions and procedures. The company also offers non-invasive medical aesthetic products for permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture improvement, and superficial benign vascular and pigmented lesions, along with hands-free products for skin tightening, fat reduction, and muscle stimulation. Its products are sold in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. Formerly known as Invasix Ltd., it changed its name to InMode Ltd. in November 2017, was incorporated in 2008, and is headquartered in Yokne'am, Israel.